Article 63EZN Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

by
from Morbidity and Mortality Weekly Report (MMWR) on (#63EZN)
This report describes the safety of the use of Tecovirimat to treat monkeypox.
External Content
Source RSS or Atom Feed
Feed Location http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Feed Title Morbidity and Mortality Weekly Report (MMWR)
Feed Link https://www.cdc.gov/mmwr/index.html
Reply 0 comments